S1406
|
SWOG
|
Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
S1416
|
SWOG
|
Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer with or Without Brain Metastases
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1418
|
SWOG
|
A Randomized; Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/=1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1500
|
SWOG
|
A Randomized; Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968]; Crizotinib [NSC #749005]; Savolitinib [NSC #785348]; and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1501
|
SWOG
|
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer; Phase III
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S1505
|
SWOG
|
A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/NAB-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1507
|
SWOG
|
A Phase II Trial of Trametinib with Docetaxel in Patients with Kras Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1512
|
SWOG
|
A Phase II and Pilot Trial of PD-1 Blockade with MK-3475 (Pembrolizumab) in Patients with Resectable or Unresectable Desmoplastic Melanoma (DM)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1513
|
SWOG
|
Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
S1600
|
SWOG
|
A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|